659P Combination treatment with TTX-030, a first-in-class anti-CD39 antibody, in patients with advanced pancreatic cancer
Authors:
- Z.A. WainbergZWZ.A. Wainberg
- Y. ChaYCY. Cha
- B. GeorgeBGB. George
- J.S. GrewalJGJ.S. Grewal
- J.R. MerchanJMJ.R. Merchan
- M. MckeanMMM. Mckean
- H.P. SoaresHSH.P. Soares
- T.D. CruzTCT.D. Cruz
- A.K. MoestaAMA.K. Moesta
- T.M. JahnTJT.M. Jahn
- A.K. SinghalASA.K. Singhal
- C. TribouleyCTC. Tribouley
- 17 September 2024
- journal article
- Published by Elsevier in Annals of Oncology
- Vol. 35, S519-S520